Literature DB >> 6759092

Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

G P Wormser, G T Keusch, R C Heel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6759092     DOI： 10.2165/00003495-198224060-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  412 in total

1.  Treatment of toxoplasmosis with trimethoprim-sulphamethoxazole.

Authors:  R Norrby; T Eilard; A Svedhem; E Lycke
Journal:  Scand J Infect Dis       Date:  1975

2.  R-factor mediated dihydrofolate reductases which confer trimethoprim resistance.

Authors:  S G Amyes; J T Smith
Journal:  J Gen Microbiol       Date:  1978-08

Review 3.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

4.  Chronic urinary tract infections. Remission rates with trimethoprim and-or sulfamethoxazole or indanyl carbenicillin.

Authors:  H Seneca; H H Zinsser; A Uson
Journal:  N Y State J Med       Date:  1974-03

5.  Pharmacokinetic studies of trimethoprim-sulfamethoxazole in children with gastroenteritis.

Authors:  M I Marks; M Kazemi; B Hales; A H Neims
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

6.  Sulphamethoxazole-trimethoprim: the first two years.

Authors:  D S Reeves
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

7.  Deterioration in renal function in association with co-trimoxazole therapy.

Authors:  R R Bailey; P J Little
Journal:  Med J Aust       Date:  1976-06-12       Impact factor: 7.738

8.  Trimethoprim/sulfamethoxazole-associated pseudomembranous colitis.

Authors:  S A Scott
Journal:  Drug Intell Clin Pharm       Date:  1982-03

9.  Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers.

Authors:  D A Sack; D C Kaminsky; R B Sack; I A Wamola; F Orskov; I Orskov; R C Slack; R R Arthur; A Z Kapikian
Journal:  Johns Hopkins Med J       Date:  1977-08

10.  Trimethoprim resistance in Finland after five years' use of plain trimethoprim.

Authors:  P Huovinen; P Toivanen
Journal:  Br Med J       Date:  1980-01-12
View more
  24 in total

1.  [Use-risk consideration of anti-infective agents from the point of view of the licensing authority].

Authors:  W Christ; B Esch
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli.

Authors:  Hyun Bong Park; Zheng Wei; Joonseok Oh; Hao Xu; Chung Sub Kim; Rurun Wang; Thomas P Wyche; Grazia Piizzi; Richard A Flavell; Jason M Crawford
Journal:  Nat Microbiol       Date:  2020-07-27       Impact factor: 17.745

3.  A screen to identify small molecule inhibitors of protein-protein interactions in mycobacteria.

Authors:  Deborah Mai; Jennifer Jones; John W Rodgers; John L Hartman; Olaf Kutsch; Adrie J C Steyn
Journal:  Assay Drug Dev Technol       Date:  2011-01-31       Impact factor: 1.738

4.  Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.

Authors:  B L Lee; S Safrin; V Makrides; J G Gambertoglio
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 5.  Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.

Authors:  Yusuke Minato; Joshua M Thiede; Shannon Lynn Kordus; Edward J McKlveen; Breanna J Turman; Anthony D Baughn
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

6.  In vitro susceptibilities of oxacillin-resistant Staphylococcus aureus to dapsone and sulfamethoxazole alone and in combination with trimethoprim.

Authors:  M W Lambertus; R Y Kwok; M E Mulligan
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

Review 7.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

8.  Melioration in Anti-staphylococcal Activity of Conventional Antibiotic(s) by Organic Acids Present in the Cell Free Supernatant of Lactobacillus paraplantarum.

Authors:  Lavanya Rishi; Garima Mittal; Rajeev Kumar Agarwal; Taruna Sharma
Journal:  Indian J Microbiol       Date:  2017-07-11       Impact factor: 2.461

Review 9.  Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis.

Authors:  Nyanyiwe M Mbeye; Feiko O ter Kuile; Mary-Ann Davies; Kamija S Phiri; Matthias Egger; Gilles Wandeler
Journal:  Trop Med Int Health       Date:  2014-07-08       Impact factor: 2.622

10.  Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin.

Authors:  Mesküre Capan; Ghyslain Mombo-Ngoma; Athanasios Makristathis; Michael Ramharter
Journal:  Malar J       Date:  2010-10-29       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.